Sign up Australia
Proactive Investors - Run By Investors For Investors

XTEK secures over $4.7M of new orders for FY17

XTEK Ltd has already secured in excess of $4.7 million of orders for FY17.
XTEK secures over $4.7M of new orders for FY17
XTEK Ltd secures over $4.7M of new orders for FY17

The orders are predominantly for the supply of a range of components for the existing fleet of Small Unmanned Aerial Systems (SUAS); and the XTEK designed and manufactured Tac 2 Sniper System.

The company is expecting to secure further orders before the end of the year and in the third and fourth quarters of FY17. 

XTEK also has revenue opportunities from products and solutions developed in-house such as XTatlas, XTclave, bomb disposal robots and XTviz.


XTEK is the only listed homeland security specialist in Australia, providing high quality protective, security, tactical and forensics solutions to the government, law enforcement, military and commercial sectors.

XTEK is well placed to benefit from increased defence spending by the federal government and its push to increase local content in defence procurement.

The company will also look to benefit from growing demand for its products and services due to rising geopolitical tensions and the threat of terrorism.


XTatlas is XTEK’s live contextual video and near real -time mosaic mapping technology.

It provides real time video overlays and near real time map views of a fires, floods or tactical situations to give decision makers timely and accurate information to act decisively.

The total available world market for XTatlas is in excess of $50 million.


XTclave is a composite consolidation technology that continues to be used to produce hard armour personal protective plates for the U.S. Foreign Comparative Testing (FCT) program.

Final results from the program will be provided to the FCT office in the next month.

The main objective of the program is to create lighter body armour for the U.S. Army.

The results to date are extremely encouraging.

XTEK has begun to engage with a number of manufacturers/users of protective plates which should result in orders for the design and build of XTclave manufacturing plants.

XTclave is currently being used to make parts for the XTEK Tac 2 Sniper System order.


XTEK is expecting good news during the current financial year including:

- At least doubling of FY16 revenue, which was $3.4 million;
- Signature of a sizeable contract for the SUAS Land 129 Phase 4 project where XTEK has been selected as the preferred supplier;
- Revenue from the design, build and/or upgrade of XTclave manufacturing plants;
- Revenue from the production of products utilising XTclave; and
- Additional revenue from the agency business due to a range of new country terrorism products.

XTEK recently secured $2.5 million in funding through a share purchase plan and placement to pursue near-term growth opportunities.

This includes the commercialisation of the company’s XTatlas contextual mapping technology and XTclave advanced composite product production.

View full XTE profile View Profile

XTEK Ltd Timeline

Related Articles

September 01 2018
The tech group is increasingly expanding its geographical reach and gaining traction in China
Australian dollars
September 28 2018
The company is now achieving positive earnings before interest, tax, depreciation and amortisation results each month.
data privacy
The company's MediaConsent platform provides consumers control of their data and privacy.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use